Our findings are consistent with previous postmortem studies demonstrating capillary damage and the loss of tight junction proteins in the CJD brain [4], supporting the role of VCAM‐1 as a peripheral indicator of neurovascular activation in CJD. This evidence concerns the gene VCAM1 and Creutzfeldt Jacob disease.